Furthermore, rapamycin inhibited cell growth in tumor cell lines including CRC cell lines like Caco2, HT29 [23], which involves binding to the mammalian target of rapamycin (mTOR) whose signaling pathway is critical to cell growth, proliferation, and survival; in brief, rapamycin could inhibit most of these hallmark processes of cancer [23, 24]. This evidence concerns the gene MTOR and colorectal carcinoma.